跳至主要内容
临床试验/NCT02262091
NCT02262091已完成不适用

Strengthening Immunity of Prefrail and Frail Elderly by WGP

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
2
主要终点
Change from baseline at 4 weeks post-vaccination in antibody titers levels

研究概览

简要总结

The aim of this research is to assess the immune enhancing property of food fibers in the elderly population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female elderly volunteers equal or above age of 70
  • Pre-frail and frail subjects (based on Fried's criteria)
  • Willing to be vaccinated against influenza and having no contraindication to receive influenza vaccination
  • Having obtained his/her (or his/her legal representative's) informed consent

排除标准

  • Subject with a rapidly deteriorating health status (terminal, severe, or uncontrolled acute/chronic diseases)
  • Allergy to eggs or influenza vaccine components.
  • Subject who has received any vaccination in the last 3 months or has previously been vaccinated with the current seasonal influenza vaccine.
  • Subject who is currently taking, or has taken in the last 4 weeks, or will take immune modulating medication during the study, including steroid, immune suppressive treatment.
  • Subject who has taken antibiotics in the last 2 months prior to entering the study.
  • Subject who is consuming regularly prebiotic and/or probiotic supplements, yogurts, and/or other dietary supplements.
  • Personal or family history of Guillain-Barre syndrome
  • BMI>35 kg/m2
  • Subject who has received blood transfusion or had a blood donation during the last 4 weeks prior to the beginning of this study.
  • Subject who cannot be expected to comply with the study procedures
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study

结局指标

主要结局

Change from baseline at 4 weeks post-vaccination in antibody titers levels

时间窗: Up to 1 month

次要结局

  • Measure of seroprotection(Up to 2 months)
  • Measure the occurence of clinical endpoints(Up to 2 months)
  • Measure of seroconversion(Up to 2 months)
  • Measure of cytokines production(Up to 2 months 2014)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验